Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2010 1
2011 2
2013 1
2014 2
2015 2
2019 1
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
How do turbidite systems behave from the hydrogeological point of view? New insights and open questions coming from an interdisciplinary work in southern Italy.
Rizzo P, Severini E, Bucci A, Bocchia F, Palladino G, Riboni N, Sanangelantoni AM, Francese R, Giorgi M, Iacumin P, Bianchi F, Mucchino C, Prosser G, Mazzone D, Avagliano D, Coraggio F, Caputi A, Celico F. Rizzo P, et al. PLoS One. 2022 May 6;17(5):e0268252. doi: 10.1371/journal.pone.0268252. eCollection 2022. PLoS One. 2022. PMID: 35522687 Free PMC article.
Panitumumab after progression on cetuximab in KRAS wild-type metastatic colorectal cancer patients: a single institution experience.
Marino A, Caliolo C, Sponziello F, Nacci A, Quaranta A, Mazzoni E, Lutrino SE, Rizzo P, Calvani N, Orlando L, Schiavone P, Fedele P, D'Amico M, Chetrì MC, Cinefra M, Ferrara P, Cinieri S. Marino A, et al. Among authors: rizzo p. Tumori. 2015 Sep-Oct;101(5):524-8. doi: 10.5301/tj.5000356. Epub 2015 May 25. Tumori. 2015. PMID: 26045117
Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial.
Galetta D, Cinieri S, Pisconti S, Gebbia V, Morabito A, Borsellino N, Maiello E, Febbraro A, Catino A, Rizzo P, Montrone M, Misino A, Logroscino A, Rizzi D, Di Maio M, Colucci G. Galetta D, et al. Among authors: rizzo p. Clin Lung Cancer. 2015 Jul;16(4):262-73. doi: 10.1016/j.cllc.2014.12.002. Epub 2014 Dec 9. Clin Lung Cancer. 2015. PMID: 25582493 Free article. Clinical Trial.
Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE).
Galetta D, Pisconti S, Cinieri S, Pappagallo GL, Gebbia V, Borsellino N, Maiello E, Rinaldi A, Montrone M, Rizzo P, Marzano N, Sasso N, Febbraro A, Colucci G. Galetta D, et al. Among authors: rizzo p. Clin Lung Cancer. 2011 Nov;12(6):402-6. doi: 10.1016/j.cllc.2011.06.006. Epub 2011 Aug 10. Clin Lung Cancer. 2011. PMID: 21831718 Clinical Trial.
12 results